US Stock MarketDetailed Quotes

PRLD Prelude Therapeutics

Watchlist
  • 3.860
  • +0.060+1.58%
Close May 14 16:00 ET
  • 3.770
  • -0.090-2.33%
Post 18:54 ET
212.03MMarket Cap-2075P/E (TTM)

About Prelude Therapeutics Company

Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.

Company Profile

SymbolPRLD
Company NamePrelude Therapeutics
Listing DateSep 25, 2020
Issue Price19.00
Founded2016
CEODr. Krishna Vaddi, PhD
MarketNASDAQ
Employees128
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address175 Innovation Boulevard
CityWilmington
ProvinceDelaware
CountryUnited States of America
Zip Code19805
Phone1-302-467-1280
Websitehttp://www.preludetx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Krishna Vaddi, PhD
  • Director and Chief Executive Officer
  • 2.64M
  • Bryant D. Lim
  • Interim Chief Financial Officer, Chief Legal Officer and Corporate Secretary
  • 1.61M
  • Andrew P. Combs, PhD
  • Chief Chemistry Officer
  • --
  • Peggy A. Scherle, PhD
  • Chief Scientific Officer
  • --
  • Dr. Jane Huang, M.D.
  • President and Chief Medical Officer
  • 1.65M
  • Dr. Paul A. Friedman,M.D.
  • Chairman of the Board
  • 161.03K
  • Julian C. Baker
  • Independent Director
  • 140.03K
  • Dr. Victor Sandor, C.M.,M.D.
  • Independent Director
  • 131.03K
  • Mardi C. Dier
  • Independent Director
  • 147.03K
  • Martin Babler
  • Independent Director
  • 134.53K
  • Dr. David P. Bonita, M.D.
  • Independent Director
  • 144.53K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg